APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhaled Nitric Oxide Therapy Solutions

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Inhaled Nitric Oxide Therapy Solutions Market Analysis and Forecast 2026-2032

23 December 2025192 pages

Choose your research edition.

Industry ResearchInhaled Nitric Oxide Therapy Solutions Industry Research Report 2026103 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhaled Nitric Oxide Therapy Solutions Industry Growth and Trends Forecast to 203261 pages · $3,450 USDMarket StructureGlobal Inhaled Nitric Oxide Therapy Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhaled Nitric Oxide Therapy Solutions Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhaled Nitric Oxide Therapy Solutions Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Inhaled Nitric Oxide Therapy Solutions market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Inhaled Nitric Oxide Therapy Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Inhaled Nitric Oxide Therapy Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Inhaled Nitric Oxide Therapy Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Inhaled Nitric Oxide Therapy Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Inhaled Nitric Oxide Therapy Solutions include Air Liquide, Linde and Mallinckrodt, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Inhaled Nitric Oxide Therapy Solutions, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Inhaled Nitric Oxide Therapy Solutions, also provides the revenue of main regions and countries. Of the upcoming market potential for Inhaled Nitric Oxide Therapy Solutions, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Inhaled Nitric Oxide Therapy Solutions revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Inhaled Nitric Oxide Therapy Solutions market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Inhaled Nitric Oxide Therapy Solutions revenue, projected growth trends, production technology, application and end-user industry.

Inhaled Nitric Oxide Therapy Solutions Segment by Company

Air Liquide

Linde

Mallinckrodt

Inhaled Nitric Oxide Therapy Solutions Segment by Type

iNO Gas

Inhaled Nitric Oxide Delivery System

Inhaled Nitric Oxide Therapy Solutions Segment by Application

Hospitals

Other Healthcare System

Inhaled Nitric Oxide Therapy Solutions Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhaled Nitric Oxide Therapy Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhaled Nitric Oxide Therapy Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhaled Nitric Oxide Therapy Solutions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Inhaled Nitric Oxide Therapy Solutions in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Inhaled Nitric Oxide Therapy Solutions company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Inhaled Nitric Oxide Therapy Solutions revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Inhaled Nitric Oxide Therapy Solutions Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. iNO Gas Major Player Table 3. Inhaled Nitric Oxide Delivery System Major Player Table 4. Global Inhaled Nitric Oxide Therapy Solutions Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals Major Player Table 6. Other Healthcare System Major Player Table 7. Inhaled Nitric Oxide Therapy Solutions Industry Trends Table 8. Inhaled Nitric Oxide Therapy Solutions Industry Drivers Table 9. Inhaled Nitric Oxide Therapy Solutions Industry Opportunities and Challenges Table 10. Inhaled Nitric Oxide Therapy Solutions Industry Restraints Table 11. Global Inhaled Nitric Oxide Therapy Solutions Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Inhaled Nitric Oxide Therapy Solutions Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Inhaled Nitric Oxide Therapy Solutions Market Share by Region (2021-2026) Table 14. Global Inhaled Nitric Oxide Therapy Solutions Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Inhaled Nitric Oxide Therapy Solutions Market Share by Region (2027-2032) Table 16. Global Inhaled Nitric Oxide Therapy Solutions Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Inhaled Nitric Oxide Therapy Solutions Revenue Market Share by Players (2021-2026) Table 18. Global Inhaled Nitric Oxide Therapy Solutions Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Inhaled Nitric Oxide Therapy Solutions Key Players Headquarters & Area Served Table 20. Global Inhaled Nitric Oxide Therapy Solutions Players, Product Type & Application Table 21. Global Inhaled Nitric Oxide Therapy Solutions Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Inhaled Nitric Oxide Therapy Solutions by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Inhaled Nitric Oxide Therapy Solutions Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Inhaled Nitric Oxide Therapy Solutions Revenue Market Share by Type (2021-2026) Table 28. Global Inhaled Nitric Oxide Therapy Solutions Revenue Market Share by Type (2027-2032) Table 29. Global Inhaled Nitric Oxide Therapy Solutions Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Inhaled Nitric Oxide Therapy Solutions Revenue Market Share by Application (2021-2026) Table 33. Global Inhaled Nitric Oxide Therapy Solutions Revenue Market Share by Application (2027-2032) Table 34. Air Liquide Company Information Table 35. Air Liquide Business Overview Table 36. Air Liquide Inhaled Nitric Oxide Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Air Liquide Inhaled Nitric Oxide Therapy Solutions Product Portfolio Table 38. Air Liquide Recent Development Table 39. Linde Company Information Table 40. Linde Business Overview Table 41. Linde Inhaled Nitric Oxide Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Linde Inhaled Nitric Oxide Therapy Solutions Product Portfolio Table 43. Linde Recent Development Table 44. Mallinckrodt Company Information Table 45. Mallinckrodt Business Overview Table 46. Mallinckrodt Inhaled Nitric Oxide Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Mallinckrodt Inhaled Nitric Oxide Therapy Solutions Product Portfolio Table 48. Mallinckrodt Recent Development Table 49. North America Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2021-2026) & (US$ Million) Table 50. North America Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2027-2032) & (US$ Million) Table 51. North America Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2021-2026) & (US$ Million) Table 52. North America Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2027-2032) & (US$ Million) Table 53. North America Inhaled Nitric Oxide Therapy Solutions Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 54. North America Inhaled Nitric Oxide Therapy Solutions Revenue by Country (2021-2026) & (US$ Million) Table 55. North America Inhaled Nitric Oxide Therapy Solutions Revenue by Country (US$ Million) & (2027-2032) Table 56. Europe Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2021-2026) & (US$ Million) Table 57. Europe Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2027-2032) & (US$ Million) Table 58. Europe Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2021-2026) & (US$ Million) Table 59. Europe Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2027-2032) & (US$ Million) Table 60. Europe Inhaled Nitric Oxide Therapy Solutions Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 61. Europe Inhaled Nitric Oxide Therapy Solutions Revenue by Country (2021-2026) & (US$ Million) Table 62. Europe Inhaled Nitric Oxide Therapy Solutions Revenue by Country (US$ Million) & (2027-2032) Table 63. China Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2021-2026) & (US$ Million) Table 64. China Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2027-2032) & (US$ Million) Table 65. China Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2021-2026) & (US$ Million) Table 66. China Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2027-2032) & (US$ Million) Table 67. Asia Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2021-2026) & (US$ Million) Table 68. Asia Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2027-2032) & (US$ Million) Table 69. Asia Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2021-2026) & (US$ Million) Table 70. Asia Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2027-2032) & (US$ Million) Table 71. Asia Inhaled Nitric Oxide Therapy Solutions Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 72. Asia Inhaled Nitric Oxide Therapy Solutions Revenue by Region (US$ Million) & (2021-2026) Table 73. Asia Inhaled Nitric Oxide Therapy Solutions Revenue by Region (US$ Million) & (2027-2032) Table 74. SAMEA Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2021-2026) & (US$ Million) Table 75. SAMEA Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2027-2032) & (US$ Million) Table 76. SAMEA Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2021-2026) & (US$ Million) Table 77. SAMEA Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2027-2032) & (US$ Million) Table 78. SAMEA Inhaled Nitric Oxide Therapy Solutions Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 79. SAMEA Inhaled Nitric Oxide Therapy Solutions Revenue by Country (2021-2026) & (US$ Million) Table 80. SAMEA Inhaled Nitric Oxide Therapy Solutions Revenue by Country (US$ Million) & (2027-2032) Table 81. Research Programs/Design for This Report Table 82. Authors List of This Report Table 83. Secondary Sources Table 84. Primary Sources List of Figures Figure 1. Inhaled Nitric Oxide Therapy Solutions Image Figure 2. Global Inhaled Nitric Oxide Therapy Solutions Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhaled Nitric Oxide Therapy Solutions Market Size Share 2021 VS 2025 VS 2032 Figure 4. iNO Gas Image Figure 5. Inhaled Nitric Oxide Delivery System Image Figure 6. Global Inhaled Nitric Oxide Therapy Solutions Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Inhaled Nitric Oxide Therapy Solutions Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals Image Figure 9. Other Healthcare System Image Figure 10. Global Inhaled Nitric Oxide Therapy Solutions Market Size (US$ Million) & (2021-2032) Figure 11. Global Inhaled Nitric Oxide Therapy Solutions Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Inhaled Nitric Oxide Therapy Solutions Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Inhaled Nitric Oxide Therapy Solutions Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Inhaled Nitric Oxide Therapy Solutions Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Inhaled Nitric Oxide Therapy Solutions Revenue Market Share by Type (2021-2032) Figure 18. Global Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Inhaled Nitric Oxide Therapy Solutions Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Inhaled Nitric Oxide Therapy Solutions Revenue Market Share by Application (2021-2032) Figure 21. North America Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Inhaled Nitric Oxide Therapy Solutions Revenue Share by Type (2021-2032) Figure 23. North America Inhaled Nitric Oxide Therapy Solutions Revenue Share by Application (2021-2032) Figure 24. North America Inhaled Nitric Oxide Therapy Solutions Revenue Share by Country (2021-2032) Figure 25. United States Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Inhaled Nitric Oxide Therapy Solutions Revenue Share by Type (2021-2032) Figure 30. Europe Inhaled Nitric Oxide Therapy Solutions Revenue Share by Application (2021-2032) Figure 31. Europe Inhaled Nitric Oxide Therapy Solutions Revenue Share by Country (2021-2032) Figure 32. Germany Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Inhaled Nitric Oxide Therapy Solutions Revenue Share by Type (2021-2032) Figure 42. China Inhaled Nitric Oxide Therapy Solutions Revenue Share by Application (2021-2032) Figure 43. Asia Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Inhaled Nitric Oxide Therapy Solutions Revenue Share by Type (2021-2032) Figure 45. Asia Inhaled Nitric Oxide Therapy Solutions Revenue Share by Application (2021-2032) Figure 46. Asia Inhaled Nitric Oxide Therapy Solutions Revenue Share by Region (2021-2032) Figure 47. Japan Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Inhaled Nitric Oxide Therapy Solutions Revenue Share by Type (2021-2032) Figure 55. SAMEA Inhaled Nitric Oxide Therapy Solutions Revenue Share by Application (2021-2032) Figure 56. SAMEA Inhaled Nitric Oxide Therapy Solutions Revenue Share by Country (2021-2032) Figure 57. Brazil Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Inhaled Nitric Oxide Therapy Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • iNO Gas
  • Inhaled Nitric Oxide Delivery System
Applications
  • Hospitals
  • Other Healthcare System
Companies covered
  • Air Liquide
  • Linde
  • Mallinckrodt

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Inhaled Nitric Oxide Therapy Solutions Market by Type
  3. 1.2.1 Global Inhaled Nitric Oxide Therapy Solutions Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 iNO Gas
  5. 1.2.3 Inhaled Nitric Oxide Delivery System
  6. 1.3 Inhaled Nitric Oxide Therapy Solutions Market by Application
  7. 1.3.1 Global Inhaled Nitric Oxide Therapy Solutions Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 Other Healthcare System
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Inhaled Nitric Oxide Therapy Solutions Market Dynamics
  1. 2.1 Inhaled Nitric Oxide Therapy Solutions Industry Trends
  2. 2.2 Inhaled Nitric Oxide Therapy Solutions Industry Drivers
  3. 2.3 Inhaled Nitric Oxide Therapy Solutions Industry Opportunities and Challenges
  4. 2.4 Inhaled Nitric Oxide Therapy Solutions Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Inhaled Nitric Oxide Therapy Solutions Market Perspective (2021-2032)
  2. 3.2 Global Inhaled Nitric Oxide Therapy Solutions Growth Trends by Region
  3. 3.2.1 Global Inhaled Nitric Oxide Therapy Solutions Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Inhaled Nitric Oxide Therapy Solutions Market Size by Region (2021-2026)
  5. 3.2.3 Global Inhaled Nitric Oxide Therapy Solutions Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Inhaled Nitric Oxide Therapy Solutions Revenue by Players
  2. 4.1.1 Global Inhaled Nitric Oxide Therapy Solutions Revenue by Players (2021-2026)
  3. 4.1.2 Global Inhaled Nitric Oxide Therapy Solutions Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Inhaled Nitric Oxide Therapy Solutions Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Inhaled Nitric Oxide Therapy Solutions Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Inhaled Nitric Oxide Therapy Solutions Key Players Headquarters & Area Served
  7. 4.4 Global Inhaled Nitric Oxide Therapy Solutions Players, Product Type & Application
  8. 4.5 Global Inhaled Nitric Oxide Therapy Solutions Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Inhaled Nitric Oxide Therapy Solutions Market CR5 and HHI
  11. 4.6.3 2025 Inhaled Nitric Oxide Therapy Solutions Tier 1, Tier 2, and Tier 3
5 Inhaled Nitric Oxide Therapy Solutions Market Size by Type
  1. 5.1 Global Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2021-2032)
  3. 5.3 Global Inhaled Nitric Oxide Therapy Solutions Revenue Market Share by Type (2021-2032)
6 Inhaled Nitric Oxide Therapy Solutions Market Size by Application
  1. 6.1 Global Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2021-2032)
  3. 6.3 Global Inhaled Nitric Oxide Therapy Solutions Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Air Liquide
  2. 7.1.1 Air Liquide Company Information
  3. 7.1.2 Air Liquide Business Overview
  4. 7.1.3 Air Liquide Inhaled Nitric Oxide Therapy Solutions Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Air Liquide Inhaled Nitric Oxide Therapy Solutions Product Portfolio
  6. 7.1.5 Air Liquide Recent Developments
  7. 7.2 Linde
  8. 7.2.1 Linde Company Information
  9. 7.2.2 Linde Business Overview
  10. 7.2.3 Linde Inhaled Nitric Oxide Therapy Solutions Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Linde Inhaled Nitric Oxide Therapy Solutions Product Portfolio
  12. 7.2.5 Linde Recent Developments
  13. 7.3 Mallinckrodt
  14. 7.3.1 Mallinckrodt Company Information
  15. 7.3.2 Mallinckrodt Business Overview
  16. 7.3.3 Mallinckrodt Inhaled Nitric Oxide Therapy Solutions Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Mallinckrodt Inhaled Nitric Oxide Therapy Solutions Product Portfolio
  18. 7.3.5 Mallinckrodt Recent Developments
8 North America
  1. 8.1 North America Inhaled Nitric Oxide Therapy Solutions Revenue (2021-2032)
  2. 8.2 North America Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2021-2032)
  3. 8.2.1 North America Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2021-2026)
  4. 8.2.2 North America Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2027-2032)
  5. 8.3 North America Inhaled Nitric Oxide Therapy Solutions Revenue Share by Type (2021-2032)
  6. 8.4 North America Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2021-2032)
  7. 8.4.1 North America Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2021-2026)
  8. 8.4.2 North America Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2027-2032)
  9. 8.5 North America Inhaled Nitric Oxide Therapy Solutions Revenue Share by Application (2021-2032)
  10. 8.6 North America Inhaled Nitric Oxide Therapy Solutions Revenue by Country
  11. 8.6.1 North America Inhaled Nitric Oxide Therapy Solutions Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Inhaled Nitric Oxide Therapy Solutions Revenue by Country (2021-2026)
  13. 8.6.3 North America Inhaled Nitric Oxide Therapy Solutions Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Inhaled Nitric Oxide Therapy Solutions Revenue (2021-2032)
  2. 9.2 Europe Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2021-2032)
  3. 9.2.1 Europe Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2021-2026)
  4. 9.2.2 Europe Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2027-2032)
  5. 9.3 Europe Inhaled Nitric Oxide Therapy Solutions Revenue Share by Type (2021-2032)
  6. 9.4 Europe Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2021-2032)
  7. 9.4.1 Europe Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2021-2026)
  8. 9.4.2 Europe Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2027-2032)
  9. 9.5 Europe Inhaled Nitric Oxide Therapy Solutions Revenue Share by Application (2021-2032)
  10. 9.6 Europe Inhaled Nitric Oxide Therapy Solutions Revenue by Country
  11. 9.6.1 Europe Inhaled Nitric Oxide Therapy Solutions Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Inhaled Nitric Oxide Therapy Solutions Revenue by Country (2021-2026)
  13. 9.6.3 Europe Inhaled Nitric Oxide Therapy Solutions Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Inhaled Nitric Oxide Therapy Solutions Revenue (2021-2032)
  2. 10.2 China Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2021-2032)
  3. 10.2.1 China Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2021-2026)
  4. 10.2.2 China Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2027-2032)
  5. 10.3 China Inhaled Nitric Oxide Therapy Solutions Revenue Share by Type (2021-2032)
  6. 10.4 China Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2021-2032)
  7. 10.4.1 China Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2021-2026)
  8. 10.4.2 China Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2027-2032)
  9. 10.5 China Inhaled Nitric Oxide Therapy Solutions Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Inhaled Nitric Oxide Therapy Solutions Revenue (2021-2032)
  2. 11.2 Asia Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2021-2032)
  3. 11.2.1 Asia Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2021-2026)
  4. 11.2.2 Asia Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2027-2032)
  5. 11.3 Asia Inhaled Nitric Oxide Therapy Solutions Revenue Share by Type (2021-2032)
  6. 11.4 Asia Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2021-2032)
  7. 11.4.1 Asia Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2021-2026)
  8. 11.4.2 Asia Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2027-2032)
  9. 11.5 Asia Inhaled Nitric Oxide Therapy Solutions Revenue Share by Application (2021-2032)
  10. 11.6 Asia Inhaled Nitric Oxide Therapy Solutions Revenue by Country
  11. 11.6.1 Asia Inhaled Nitric Oxide Therapy Solutions Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Inhaled Nitric Oxide Therapy Solutions Revenue by Country (2021-2026)
  13. 11.6.3 Asia Inhaled Nitric Oxide Therapy Solutions Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Inhaled Nitric Oxide Therapy Solutions Revenue (2021-2032)
  2. 12.2 SAMEA Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Inhaled Nitric Oxide Therapy Solutions Revenue by Type (2027-2032)
  5. 12.3 SAMEA Inhaled Nitric Oxide Therapy Solutions Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Inhaled Nitric Oxide Therapy Solutions Revenue by Application (2027-2032)
  9. 12.5 SAMEA Inhaled Nitric Oxide Therapy Solutions Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Inhaled Nitric Oxide Therapy Solutions Revenue by Country
  11. 12.6.1 SAMEA Inhaled Nitric Oxide Therapy Solutions Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Inhaled Nitric Oxide Therapy Solutions Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Inhaled Nitric Oxide Therapy Solutions Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst